Metraipolis › archive › dc_744c8708b7af
Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41058614
- DOI
- 10.3389/fmed.2025.1574395
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:40:39.853Z
- SHA-256 of the archived text
8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2- Stable URL of this page
https://metraipolis.com/documento/dc_744c8708b7af
How to cite
Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614 — Europe PMC (en), https://europepmc.org/article/MED/41058614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_744c8708b7af (Metraipolis archive dc_744c8708b7af, sha256 8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2)
BibTeX
@misc{dc744c8708b7af,
title = {Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41058614},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_744c8708b7af; sha256 8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41058614. Agents can read the archived copy with the MCP tool read_document.